Susquehanna International Group, LLP Bristol Myers Squibb CO Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $69.1 Million - $90.2 Million	-1,743,500 Reduced 18.36%	7,751,800 $401 Million
Q2 2024 Aug 15, 2024	BUY	$40.25 - $52.99 $215 Million - $283 Million	5,343,700 Added 128.71%	9,495,300 $394 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $12.5 Million - $14.2 Million	-260,600 Reduced 5.91%	4,151,600 $225 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $79.6 Million - $95 Million	1,642,100 Added 59.28%	4,412,200 $226 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $52.4 Million - $58.6 Million	904,900 Added 48.51%	2,770,100 $161 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $43.1 Million - $47.8 Million	-675,900 Reduced 26.6%	1,865,200 $119 Million
Q1 2023 May 16, 2023	SELL	$65.71 - $74.53 $45.7 Million - $51.8 Million	-694,900 Reduced 21.47%	2,541,100 $176 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $5.31 Million - $6.28 Million	77,500 Added 2.45%	3,236,000 $233 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $10,738 - $6.35 Million	-82,600 Reduced 2.55%	3,158,500 $225 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.